Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 500 entries
Sorted by: Best Match Show Resources per page
A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.

European journal of nuclear medicine

Hoefnagel CA, Rutgers M, Buitenhuis CK, Smets LA, Kraker Jd, Meli M, Carrel F, Amstutz H, Schubiger PA, Novak-Hofer I.
PMID: 24623005
Eur J Nucl Med. 2001 Mar;28(3):359-68. doi: 10.1007/s002590000454.

Iodine-131 labelled anti L1-CAM antibody mAb chCE7 was compared with the effective neuroblastoma-seeking agent (131)I-labelled metaiodobenzylguanidine (MIBG) with regard to (a) its therapeutic efficacy in treating nude mice with neuroblastoma xenografts and (b) its tumour targetting ability in neuroblastoma...

Cite
Hoefnagel CA, Rutgers M, Buitenhuis CK, et al. A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. Eur J Nucl Med. 2001;28(3):359-68doi: 10.1007/s002590000454.
Hoefnagel, C. A., Rutgers, M., Buitenhuis, C. K., Smets, L. A., Kraker, J. d., Meli, M., Carrel, F., Amstutz, H., Schubiger, P. A., & Novak-Hofer, I. (2001). A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. European journal of nuclear medicine, 28(3), 359-68. https://doi.org/10.1007/s002590000454
Hoefnagel, C A, et al. "A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients." European journal of nuclear medicine vol. 28,3 (2001): 359-68. doi: https://doi.org/10.1007/s002590000454
Hoefnagel CA, Rutgers M, Buitenhuis CK, Smets LA, Kraker Jd, Meli M, Carrel F, Amstutz H, Schubiger PA, Novak-Hofer I. A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. Eur J Nucl Med. 2001 Mar;28(3):359-68. doi: 10.1007/s002590000454. PMID: 24623005.
Copy Download .nbib Format: NLM
Reply.

European journal of nuclear medicine

Sabri O.
PMID: 24623006
Eur J Nucl Med. 2001 Mar;28(3):394-5. doi: 10.1007/s002590000467.

No abstract available.

Cite
Sabri O. Reply. Eur J Nucl Med. 2001;28(3):394-5doi: 10.1007/s002590000467.
Sabri, O. (2001). Reply. European journal of nuclear medicine, 28(3), 394-5. https://doi.org/10.1007/s002590000467
Sabri, O. "Reply." European journal of nuclear medicine vol. 28,3 (2001): 394-5. doi: https://doi.org/10.1007/s002590000467
Sabri O. Reply. Eur J Nucl Med. 2001 Mar;28(3):394-5. doi: 10.1007/s002590000467. PMID: 24623006.
Copy Download .nbib Format: NLM
Erratum to PET imaging with hypoxia tracers: a must in radiation therapy.

European journal of nuclear medicine and molecular imaging

Lucignani G.
PMID: 28289875
Eur J Nucl Med Mol Imaging. 2008 May;35(5):1033. doi: 10.1007/s00259-008-0764-7.

No abstract available.

Cite
Lucignani G. Erratum to PET imaging with hypoxia tracers: a must in radiation therapy. Eur J Nucl Med Mol Imaging. 2008;35(5):1033doi: 10.1007/s00259-008-0764-7.
Lucignani, G. (2008). Erratum to PET imaging with hypoxia tracers: a must in radiation therapy. European journal of nuclear medicine and molecular imaging, 35(5), 1033. https://doi.org/10.1007/s00259-008-0764-7
Lucignani, Giovanni. "Erratum to PET imaging with hypoxia tracers: a must in radiation therapy." European journal of nuclear medicine and molecular imaging vol. 35,5 (2008): 1033. doi: https://doi.org/10.1007/s00259-008-0764-7
Lucignani G. Erratum to PET imaging with hypoxia tracers: a must in radiation therapy. Eur J Nucl Med Mol Imaging. 2008 May;35(5):1033. doi: 10.1007/s00259-008-0764-7. PMID: 28289875.
Copy Download .nbib Format: NLM
Increased arterial inflammation in individuals with stage 3 chronic kidney disease.

European journal of nuclear medicine and molecular imaging

Takx RAP, MacNabb MH, Emami H, Abdelbaky A, Singh P, Lavender ZR, di Carli M, Taqueti V, Foster C, Mann J, Comley RA, Weber CIK, Tawakol A.
PMID: 26464074
Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):333-339. doi: 10.1007/s00259-015-3203-6. Epub 2015 Oct 14.

PURPOSE: While it is well known that patients with chronic kidney disease (CKD) are at increased risk for the development and progression of atherosclerosis, it is not known whether arterial inflammation is increased in mild CKD. The aim of...

Cite
Takx RAP, MacNabb MH, Emami H, et al. Increased arterial inflammation in individuals with stage 3 chronic kidney disease. Eur J Nucl Med Mol Imaging. 2015;43(2):333-339doi: 10.1007/s00259-015-3203-6.
Takx, R. A. P., MacNabb, M. H., Emami, H., Abdelbaky, A., Singh, P., Lavender, Z. R., di Carli, M., Taqueti, V., Foster, C., Mann, J., Comley, R. A., Weber, C. I. K., & Tawakol, A. (2016). Increased arterial inflammation in individuals with stage 3 chronic kidney disease. European journal of nuclear medicine and molecular imaging, 43(2), 333-339. https://doi.org/10.1007/s00259-015-3203-6
Takx, Richard A P, et al. "Increased arterial inflammation in individuals with stage 3 chronic kidney disease." European journal of nuclear medicine and molecular imaging vol. 43,2 (2016): 333-339. doi: https://doi.org/10.1007/s00259-015-3203-6
Takx RAP, MacNabb MH, Emami H, Abdelbaky A, Singh P, Lavender ZR, di Carli M, Taqueti V, Foster C, Mann J, Comley RA, Weber CIK, Tawakol A. Increased arterial inflammation in individuals with stage 3 chronic kidney disease. Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):333-339. doi: 10.1007/s00259-015-3203-6. Epub 2015 Oct 14. PMID: 26464074; PMCID: PMC4833679.
Copy Download .nbib Format: NLM
Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.

European journal of nuclear medicine and molecular imaging

Temple W, Mendelsohn L, Kim GE, Nekritz E, Gustafson WC, Lin L, Giacomini K, Naranjo A, Van Ryn C, Parisi MT, Shulkin BL, Yanik GA, Kreissman SG, Hogarty M, Matthay KK, DuBois SG.
PMID: 27044383
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1396. doi: 10.1007/s00259-016-3381-x.

No abstract available.

Cite
Temple W, Mendelsohn L, Kim GE, et al. Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group. Eur J Nucl Med Mol Imaging. 2016;43(7):1396doi: 10.1007/s00259-016-3381-x.
Temple, W., Mendelsohn, L., Kim, G. E., Nekritz, E., Gustafson, W. C., Lin, L., Giacomini, K., Naranjo, A., Van Ryn, C., Parisi, M. T., Shulkin, B. L., Yanik, G. A., Kreissman, S. G., Hogarty, M., Matthay, K. K., & DuBois, S. G. (2016). Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group. European journal of nuclear medicine and molecular imaging, 43(7), 1396. https://doi.org/10.1007/s00259-016-3381-x
Temple, William, et al. "Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group." European journal of nuclear medicine and molecular imaging vol. 43,7 (2016): 1396. doi: https://doi.org/10.1007/s00259-016-3381-x
Temple W, Mendelsohn L, Kim GE, Nekritz E, Gustafson WC, Lin L, Giacomini K, Naranjo A, Van Ryn C, Parisi MT, Shulkin BL, Yanik GA, Kreissman SG, Hogarty M, Matthay KK, DuBois SG. Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1396. doi: 10.1007/s00259-016-3381-x. PMID: 27044383.
Copy Download .nbib Format: NLM
Erratum to: Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis.

European journal of nuclear medicine and molecular imaging

Kuhnert G, Boellaard R, Sterzer S, Kahraman D, Scheffler M, Wolf J, Dietlein M, Drzezga A, Kobe C.
PMID: 26481912
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):204-205. doi: 10.1007/s00259-015-3230-3.

No abstract available.

Cite
Kuhnert G, Boellaard R, Sterzer S, et al. Erratum to: Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis. Eur J Nucl Med Mol Imaging. 2016;43(1):204-205doi: 10.1007/s00259-015-3230-3.
Kuhnert, G., Boellaard, R., Sterzer, S., Kahraman, D., Scheffler, M., Wolf, J., Dietlein, M., Drzezga, A., & Kobe, C. (2016). Erratum to: Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis. European journal of nuclear medicine and molecular imaging, 43(1), 204-205. https://doi.org/10.1007/s00259-015-3230-3
Kuhnert, Georg, et al. "Erratum to: Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis." European journal of nuclear medicine and molecular imaging vol. 43,1 (2016): 204-205. doi: https://doi.org/10.1007/s00259-015-3230-3
Kuhnert G, Boellaard R, Sterzer S, Kahraman D, Scheffler M, Wolf J, Dietlein M, Drzezga A, Kobe C. Erratum to: Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis. Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):204-205. doi: 10.1007/s00259-015-3230-3. PMID: 26481912.
Copy Download .nbib Format: NLM
(99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.

European journal of nuclear medicine

Blower PJ, Kettle AG, O'Doherty MJ, Coakley AJ, Knapp FF.
PMID: 25084779
Eur J Nucl Med. 2000 Sep;27(9):1405-9. doi: 10.1007/s002590000307.

Rhenium-188 dimercaptosuccinic acid complex [(188)Re(V)DMSA], a potential therapeutic analogue of the tumour imaging agent (99m)Tc(V)DMSA, is selectively taken up in bone metastases in patients with prostate cancer. It would be helpful in planning palliative radionuclide therapy if (99m)Tc(V)DMSA could...

Cite
Blower PJ, Kettle AG, O'Doherty MJ, et al. (99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to bone. Eur J Nucl Med. 2000;27(9):1405-9doi: 10.1007/s002590000307.
Blower, P. J., Kettle, A. G., O'Doherty, M. J., Coakley, A. J., & Knapp, F. F. (2000). (99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to bone. European journal of nuclear medicine, 27(9), 1405-9. https://doi.org/10.1007/s002590000307
Blower, P J, et al. "(99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to bone." European journal of nuclear medicine vol. 27,9 (2000): 1405-9. doi: https://doi.org/10.1007/s002590000307
Blower PJ, Kettle AG, O'Doherty MJ, Coakley AJ, Knapp FF. (99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to bone. Eur J Nucl Med. 2000 Sep;27(9):1405-9. doi: 10.1007/s002590000307. PMID: 25084779.
Copy Download .nbib Format: NLM
Erratum: Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis.

European journal of nuclear medicine

Hustinx R, Dolin RJ, Bénard F, Bhatnagar A, Chakraborty D, Smith RJ, Jang S, Alavi A.
PMID: 25084780
Eur J Nucl Med. 2000 Sep;27(9):1435. doi: 10.1007/s002590000326.

No abstract available.

Cite
Hustinx R, Dolin RJ, Bénard F, et al. Erratum: Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis. Eur J Nucl Med. 2000;27(9):1435doi: 10.1007/s002590000326.
Hustinx, R., Dolin, R. J., Bénard, F., Bhatnagar, A., Chakraborty, D., Smith, R. J., Jang, S., & Alavi, A. (2000). Erratum: Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis. European journal of nuclear medicine, 27(9), 1435. https://doi.org/10.1007/s002590000326
Hustinx, R, et al. "Erratum: Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis." European journal of nuclear medicine vol. 27,9 (2000): 1435. doi: https://doi.org/10.1007/s002590000326
Hustinx R, Dolin RJ, Bénard F, Bhatnagar A, Chakraborty D, Smith RJ, Jang S, Alavi A. Erratum: Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis. Eur J Nucl Med. 2000 Sep;27(9):1435. doi: 10.1007/s002590000326. PMID: 25084780.
Copy Download .nbib Format: NLM
Doctors cannot escape politics and neither can medical journals.

European journal of nuclear medicine

Kleinert S, Horton R.
PMID: 10744465
Eur J Nucl Med. 2000;27(1):S13-5. doi: 10.1007/s002590050508.

No abstract available.

Cite
Kleinert S, Horton R. Doctors cannot escape politics and neither can medical journals. Eur J Nucl Med. 2000;27(1):S13-5doi: 10.1007/s002590050508.
Kleinert, S., & Horton, R. (2000). Doctors cannot escape politics and neither can medical journals. European journal of nuclear medicine, 27(1), S13-5. https://doi.org/10.1007/s002590050508
Kleinert, S, and Horton, R. "Doctors cannot escape politics and neither can medical journals." European journal of nuclear medicine vol. 27,1 (2000): S13-5. doi: https://doi.org/10.1007/s002590050508
Kleinert S, Horton R. Doctors cannot escape politics and neither can medical journals. Eur J Nucl Med. 2000;27(1):S13-5. doi: 10.1007/s002590050508. PMID: 10744465.
Copy Download .nbib Format: NLM
Navigating beyond the 6th dimension: a challenge in the era of multi-parametric molecular imaging.

European journal of nuclear medicine and molecular imaging

Zaidi H.
PMID: 19247650
Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1025-8. doi: 10.1007/s00259-009-1095-z.

No abstract available.

Cite
Zaidi H. Navigating beyond the 6th dimension: a challenge in the era of multi-parametric molecular imaging. Eur J Nucl Med Mol Imaging. 2009;36(7):1025-8doi: 10.1007/s00259-009-1095-z.
Zaidi, H. (2009). Navigating beyond the 6th dimension: a challenge in the era of multi-parametric molecular imaging. European journal of nuclear medicine and molecular imaging, 36(7), 1025-8. https://doi.org/10.1007/s00259-009-1095-z
Zaidi, Habib. "Navigating beyond the 6th dimension: a challenge in the era of multi-parametric molecular imaging." European journal of nuclear medicine and molecular imaging vol. 36,7 (2009): 1025-8. doi: https://doi.org/10.1007/s00259-009-1095-z
Zaidi H. Navigating beyond the 6th dimension: a challenge in the era of multi-parametric molecular imaging. Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1025-8. doi: 10.1007/s00259-009-1095-z. PMID: 19247650.
Copy Download .nbib Format: NLM
Bone marrow uptake of (99m)Tc-MIBI in patients with multiple myeloma.

European journal of nuclear medicine

Blocklet D, Schoutens E, Kentos A, Feremans W.
PMID: 24578058
Eur J Nucl Med. 2001 Sep;28(9):1432. doi: 10.1007/s002590100576.

No abstract available.

Cite
Blocklet D, Schoutens E, Kentos A, et al. Bone marrow uptake of (99m)Tc-MIBI in patients with multiple myeloma. Eur J Nucl Med. 2001;28(9):1432doi: 10.1007/s002590100576.
Blocklet, D., Schoutens, E., Kentos, A., & Feremans, W. (2001). Bone marrow uptake of (99m)Tc-MIBI in patients with multiple myeloma. European journal of nuclear medicine, 28(9), 1432. https://doi.org/10.1007/s002590100576
Blocklet, D, et al. "Bone marrow uptake of (99m)Tc-MIBI in patients with multiple myeloma." European journal of nuclear medicine vol. 28,9 (2001): 1432. doi: https://doi.org/10.1007/s002590100576
Blocklet D, Schoutens E, Kentos A, Feremans W. Bone marrow uptake of (99m)Tc-MIBI in patients with multiple myeloma. Eur J Nucl Med. 2001 Sep;28(9):1432. doi: 10.1007/s002590100576. PMID: 24578058.
Copy Download .nbib Format: NLM
In vivo evaluation of (111)In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection.

European journal of nuclear medicine

Kulasegaram R, Giersing B, Page C, Blower P, Williamson R, Peters B, O'Doherty M.
PMID: 24777542
Eur J Nucl Med. 2001 Jun;28(6):756-61. doi: 10.1007/s002590100522.

Matrix metalloproteinases are the major agents responsible for the degradation of extracellular matrix and are produced at high levels by transformed and tumour cells, where they participate in the metastatic process by allowing local invasion. They are also more...

Cite
Kulasegaram R, Giersing B, Page C, et al. In vivo evaluation of (111)In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection. Eur J Nucl Med. 2001;28(6):756-61doi: 10.1007/s002590100522.
Kulasegaram, R., Giersing, B., Page, C., Blower, P., Williamson, R., Peters, B., & O'Doherty, M. (2001). In vivo evaluation of (111)In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection. European journal of nuclear medicine, 28(6), 756-61. https://doi.org/10.1007/s002590100522
Kulasegaram, R, et al. "In vivo evaluation of (111)In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection." European journal of nuclear medicine vol. 28,6 (2001): 756-61. doi: https://doi.org/10.1007/s002590100522
Kulasegaram R, Giersing B, Page C, Blower P, Williamson R, Peters B, O'Doherty M. In vivo evaluation of (111)In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection. Eur J Nucl Med. 2001 Jun;28(6):756-61. doi: 10.1007/s002590100522. PMID: 24777542.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 500 entries